Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica.
about
Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukesPopulation dynamics of the liver fluke, Fasciola hepatica: the effect of time and spatial separation on the genetic diversity of fluke populations in the Netherlands.Triclabendazole progress report, 2005-2009: an advancement of learning?Electron microscopical study to assess the in vitro effects of the synthetic trioxolane OZ78 against the liver fluke, Fasciola hepatica.Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica.Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.Erratum to: inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.Characterization of the xenobiotic response of Caenorhabditis elegans to the anthelmintic drug albendazole and the identification of novel drug glucoside metabolites.Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole.Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil.Pleiotropic alterations in gene expression in Latin American Fasciola hepatica isolates with different susceptibility to drugs.
P2860
Q33529290-A9137953-49CC-427C-B334-01FCA96BD879Q33676277-80B62C7E-C28A-4C91-B198-F0B817E93925Q37444251-73CF468D-956F-460C-8C4F-8FAC1F8E3505Q42458074-E8BDD04D-16E7-47F5-8213-17401D857621Q42478334-E1B74CEE-40D5-4581-8DFC-058A92C9265AQ42485937-E8A285A8-64B6-4ECD-A440-F7C698D499D8Q42493268-DFFBB714-552C-4748-A584-0EC486B9EB56Q42867393-C4DC80D4-677D-471F-B336-C0DFB4100208Q43212883-94AA0A3A-0BD1-4C7F-AB19-1D235EBF278EQ43788758-E40C60AB-4B6C-4A30-A69B-E7C8FED859F2Q49197054-7206C870-4656-4002-A8EF-8E42BDB86BD6
P2860
Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Effect of the metabolic inhibi ...... isolate of Fasciola hepatica.
@en
Effect of the metabolic inhibi ...... isolate of Fasciola hepatica.
@nl
type
label
Effect of the metabolic inhibi ...... isolate of Fasciola hepatica.
@en
Effect of the metabolic inhibi ...... isolate of Fasciola hepatica.
@nl
prefLabel
Effect of the metabolic inhibi ...... isolate of Fasciola hepatica.
@en
Effect of the metabolic inhibi ...... isolate of Fasciola hepatica.
@nl
P2093
P2860
P1433
P1476
Effect of the metabolic inhibi ...... isolate of Fasciola hepatica.
@en
P2093
A Trudgett
C E Lanusse
G P Brennan
I Fairweather
L I Alvarez
P2860
P304
P356
10.1017/S0031182008005222
P577
2008-12-12T00:00:00Z